You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Both teams had sequencing data generated at BGI and said that going forward, it would be important to validate the technology outside of BGI.
Startup AiLife Diagnostics is contributing its NGS analysis, interpretation, and reporting pipelines to BGI's $600 DNBseq WGS assay.
The suit alleges that BGI's sequencing products and reagents infringe a European patent held by Illumina.
Using BGI's sequencing technology, the firms plan to commercialize Natera's Signatera test in China and to develop reproductive health tests in "select markets."
At the AGBT conference, MGI Tech showcased its technologies, while a Sanger Institute researcher presented results from a comparison between BGI and Illumina data.
The Shenzhen, China-based BGI subsidiary plans to expand its business to the United Arab Emirates, Qatar, Saudi Arabia, and other countries.
The effort, led by BGI-Shenzen researchers, could help further plant sequencing studies and inform upcoming large-scale plant sequencing plans.
CNGB was founded by the Chinese government and BGI to collect genomics technologies and resources, and promote their use by the research community.
The partners said they have agreed to work together on projects in a range of diseases, as well as establish research alliances with groups in China and Africa.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.